Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
alpha-synuclein
Alzheimer's disease
amygdala
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, guamian type of
amyotrophic lateral sclerosis, Parkinson-dementia-complex
anticholinergic drugs
anticipation
ataxia
biologic markers
blacks
blinking, reduced
bradykinesia
brain transplantation
camptocormia
cardiomyopathy
CAT scan, emission
children
chronic progressive external ophthalmoplegia
cigarette smoking
cluster headache
cluster headache, pathogenesis
coenzyme Q10
controversies in neurology
cycad seed flour
DATATOP study
degenerative diseases of CNS
dementia
deprenyl
depression
diet
dopamine agonist
dopaminergic dysfunction
dopaminergic neurons
encephalitis
encephalitis, viral
encephalopathy
epidemiology of neurology
excitotoxin
exercise intolerance
eye, pain in
falling
familial
farmer
fetal tissue
fine motor function, impaired
free radical
gait disorder
gait, festinating
gene
gene mutation
gene therapy
genetic neurologic disorders
glabellar sign
handwriting
head injury
headache
headache, awakened by
headache, hypnic
headache, intractable
headache, severe
headache, unilateral
hearing loss
hepatic failure
hepatitis
hepatitis B virus
hepatitis C virus
herbicide
hypometric saccades
hypothalamus
hypothalamus, disturbance of
imbalance
imbalance, postural
insecticides
iron, brain
kinesia paradoxica
L-dopa
L-dopa, drug interactions with and side effects of
Lewy body
Lewy body disease, diffuse
locus ceruleus, lesion of
marche a petits pas
masked facies
micrographia
migraine
mitochondrial disease
mitochondrial disease, pathogenesis
molecular genetics
monoamine oxidase inhibitors
mortality
movement disorder
MPTP
MRI
MRI, functional
MRS
myopathy
neuroleptic, atypical
neurologic disease
neurologic disease, diagnoses of
neurologic signs
neuronal degeneration
neurons
neuropathology
neuropathology, brain
neuropathy
neuroprotective agents
neurotoxic
neurotoxin
nigrostriatal pathway
occupational neurologic disorders
old age, neurology of
ophthalmoplegia
ophthalmoplegia, progressive external
oxidative phosphorylation
oxidative phosphorylation defect
pain, deep brain stimulation for control of
pain, periorbital
pallidotomy
Parkinson disease
Parkinson disease, classification
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, etiology of
Parkinson disease, familial
Parkinson disease, freezing phenomena in
Parkinson disease, heterogeneity of
Parkinson disease, late onset
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, racial prevalence
Parkinson disease, subtypes
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, young onset
Parkinsonism syndrome
pathology
placebo effect
poison, organophosphate
POLG1 gene
prevention of neurologic disorders
PRKN gene
prognosis
progressive neurologic disorder
psychosis
ptosis
raphe nuclei
review article
rigidity
risk factors
seizure
sinemet
single photon emission computed tomography
skin, biopsy
smell
speech, soft
stare
stem cell transplantation
stimulation, deep brain
strokelike episodes
substantia nigra
subthalamic nucleus
subthalamic nucleus deep brain stimulation
synucleinopathy
systemic illness
toxins, nervous system
treatment of neurologic disorder
tremor
tremor, resting
tremor, thalamic stimulation for suppression of
twins
viral infection
viral infection, CNS
vitamin E
web sites
Showing articles 700 to 750 of 1815 << Previous Next >>

Pathologic Heterogeneity in Clinically Diagnosed Corticobasal Degeneration
Neurol 53:795-800, Boeve,B.F.,et al, 1999

Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation
NEJM 341:1003-1004, Bezerra,M.L.S.,et al, 1999

Serum Vitamin A Concentration is Elevated in Idiopathic Intracranial Hypertension
Neurol 53:1114-1118, Jacobson,D.M.,et al, 1999

Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease
NEJM 341:988-992, Freeman,T.B.,et al, 1999

Stereotactic Pallidotomy in the Treatment of Parkinson Disease,An Expert Opinion
Arch Neurol 56:1064-1069, Bronstein,J.M.,et al, 1999

Immediate-Release and Controlled-Release Carbidopa/Levodopa in PD, A 5-Year Randomized Multicenter Study
Neurol 53:1012-1019, Koller,W.C.,et al, 1999

Bilateral Thalamic Stimulation for the Treatment of Essential Tremor
Neurol 53:1447-1450, Pahwa,R.,et al, 1999

Neuropsychological and Quality of Life Outcome after Thalamic Stimulation for Essential Tremor
Neurol 53:1774-1780, Troster,A.I.,et al, 1999

Progress in Functional Neurosurgery for Parkinson's Disease
Lancet 354:1658-1659,1665, Quinn,N., 1999

Diagnosing Dementia with Lewy Bodies
Lancet 354:1227-1228, McKeith,I.G.,et al, 1999

Bilateral Substantia Nigra Changes on MRI in a Patient with Encephalitis Lethargica
Neurol 53:1860-1862, Kun,L.N.,et al, 1999

Unilateral Pallidotomy for Parkinson's Disease:Results after More Than 1 Year
JNNP 67:511-517, Schrag,A.,et al, 1999

Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999

Dementia as the Most Common Presentation of Cortical-Basal Ganglionic Degeneration
Neurol 53:1969-1974, Grimes,D.A.,et al, 1999

Prevalence of Progressive Supranuclear Palsy and Multiple System Atrophy:A Cross-Sectional Study
Lancet 354:1771-1775, Schrag,A.,et al, 1999

Evaluation of Surgery for Parkinson's Disease, A Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 53:1910-1921, Hallett,M.,et al, 1999

Restless Legs Syndrome Improved By Pramipecole, A Double-Blind Randomized Trial
Neurol 52:938-943, Montplaisir,J.,et al, 1999

Parkinsonism after Taking Ecstasy
NEJM 340:1443, Mintzer,S.,et al, 1999

Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation
NEJM 340:1476-1480,1500, Bejjani,B-P.,et al, 1999

Clinicopath Conf:Multisystem Neurodegenerative Disease with Dementia Pugilistica
NEJM 340:1269-1277, Case 12-1999, 1999

The Effect of Estrogen Replacement on Early Parkinson's Disease
Neurol 52:1417-1421, Sanders-Pullman,R.,et al, 1999

Prevalence and Clinical Correlates of Psychotic Symptoms in parkinson Disease
Arch Neurol 56:595-601, Aarsland,D.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Progression of Parkinsonian Signs in Parkinson Disease
Arch Neurol 56:334-337, Louis,E.D.,et al, 1999

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

Neurologic Side Effects in Neuroleptic-Naive Patients Treated with Haloperidol or Risperidone
Neurol 52:782-785, Rosebush,P.I.&Mazurek,M.F., 1999

Diagnostic Criteria for Parkinson Disease
Arch Neurol 56:33-39, Gelb,D.J.,et al, 1999

Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999

Susceptibility to Neuroleptic Malignant Syndrome in Parkinson's Disease
Neurol 52:777-781, Ueda,M.,et al, 1999

Multicentre European Study of Thalamic Stimulation in Paarkinsonisn and Essential Tremor
JNNP 66:289-296, Limousin,P.,et al, 1999

A Controlled Study of Additional sr-L-dopa in L-dopa-responsive Restless Legs Syndrome with Late-Night Symptoms
Neurol 52:285-290, Collado-Seidel,V.,et al, 1999

Dementia Following Treatment of Brain Tumors with Radiotherapy Administered Alone or in Combination with Nitrosourea-Based Chemotherapy: A Clinical and Pathological Study
J Neurooncol 41:137-149, Vigliani,M.C.,et al, 1999

Delayed Movement Disorders After Carbon Monoxide Poisoning
Eur Neurol 42:141-144, Choi,I.S. &Cheon,H.Y., 1999

Neurological Manifestations of Chronic Hepatitis C
J Neurol 246:486-491, Heckmann, J.G.,et al, 1999

Subcotical Arteriosclerotic Encephalopathy (Binswangers Disease)
, Ghika,J. &Bogousslavsky, J., 1998

Randomized,Double-Blind,Placebo-Controlled Trial of Pergolide in Restless Leg Syndrome
Neurol 51:1599-1602, Earley,C.J.,et al, 1998

Encouraging Initial Response of Restless Legs Syndrome to Pramipexole
Neurol 51:1221-123, Becker,P.M.,et al, 1998

The Spectrum of Antecedent Infections in Guillain-Barre Syndrome
Neurol 51:1110-1115, Jacobs,B.C.,et al, 1998

Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998

Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 339:1105-1111, Limousin,P.,et al, 1998

Unilateral Thalamic Deep Brain Stimulation for Refractory Essential Tremor and Parkinson's Disease Tremor
Neurol 51:1063-1069, Ondo,W.,et al, 1998

Bilateral High-Frequency Stimulation of the Internal Globus Pallidus in Advanced Parkinson's Disease
Ann Neurol 44:953-961, Volkmann,J.,et al, 1998

Atrophy of the Corpus Callosum, Cortical Hypometabolism, and Cognitive Impairment in Corticobasal Degeneration
Arch Neurol 55:609-614, Yamauchi,H.,et al, 1998

Clinical Presentation and Pharmacological Therapy in Corticobasal Degeneration
Arch Neurol 55:957-961, Kompoliti,K.,et al, 1998

Is Exposure to Aluminum a Risk Factor for the Development of Alzheimer Disease? -Yes
Neurol 55:740-742, Forbes,W.F.&Hill,G.B., 1998

Is Exposure to Aluminum a Risk Factor for the Development of Alzheimer Disease? -No
Arch Neurol 55:737-739, 7421998., Munoz,D.G., 1998

Smoking and Risk of Dementia and Alzheimer's Disease in a Population-Based Cohort Study:The Rotterdam Study
lancet 351:1840-1843, Ott,A.,et al, 1998

Practice Styles of US Compared to UK Neurologists
Neurol 50:1661-1668, Vickrey,B.G.,et al, 1998

Postmenopausal Estrogen Use and Parkinson's Disease with and without Dementia
Neurol 50:1141-1143, Marder,K.,et al, 1998

Hypothalamic Activation in Cluster Headache Attacks
Lancet 352:275-278, 2531998., May,A.,et al, 1998



Showing articles 700 to 750 of 1815 << Previous Next >>